These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 29730911)
1. [Prognostic factors analysis of Ki-67, α-SMA expression in retroperitoneal leiomyosarcoma]. Ma C; Li PY; Zhang N; Sun CB; Hou L; Liu N Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):258-263. PubMed ID: 29730911 [No Abstract] [Full Text] [Related]
2. [Expression of CD133 in primary retroperitoneal leiomyosarcoma and its relationship with Ki-67]. She Y; Liang J; Qiu Y; Liu N; Huang X; Zhao X; Li P Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(16):1241-4. PubMed ID: 24924889 [TBL] [Abstract][Full Text] [Related]
3. CREPT expression correlates with poor prognosis in patients with retroperitoneal leiomyosarcoma. She Y; Liang J; Chen L; Qiu Y; Liu N; Zhao X; Huang X; Wang Y; Ren F; Chang Z; Li P Int J Clin Exp Pathol; 2014; 7(10):6596-605. PubMed ID: 25400738 [TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in patients with recurrent or metastatic retroperitoneal leiomyosarcoma. Li Q; Zhuang R; Zhu J; Lu W; Hou Y; Liu J; Zhang Y; Wang Y; Liu T; Wang Z; Zhou Y Future Oncol; 2015; 11(12):1759-66. PubMed ID: 26075444 [TBL] [Abstract][Full Text] [Related]
6. Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomas. Morizawa Y; Miyake M; Shimada K; Hori S; Tatsumi Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K World J Surg Oncol; 2016 Feb; 14(1):43. PubMed ID: 26911364 [TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors predicting postoperative survival period in the treatment of primary retroperitoneal leiomyosarcoma]. Zhao XD; Li PY; Huang XH; Chen L; Li R; Liu N Zhonghua Wai Ke Za Zhi; 2013 Oct; 51(10):891-4. PubMed ID: 24433766 [TBL] [Abstract][Full Text] [Related]
8. Leiomyosarcoma: One disease or distinct biologic entities based on site of origin? Worhunsky DJ; Gupta M; Gholami S; Tran TB; Ganjoo KN; van de Rijn M; Visser BC; Norton JA; Poultsides GA J Surg Oncol; 2015 Jun; 111(7):808-12. PubMed ID: 25920434 [TBL] [Abstract][Full Text] [Related]
9. [Predictors of local recurrence and survival in primary retroperitoneal leiomyosarcoma]. Chen G; Yan Y; Xiao C; Sun P; Xue H; Li R Zhonghua Wai Ke Za Zhi; 2014 Feb; 52(2):105-8. PubMed ID: 24809517 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of putative molecular biomarkers in abdominal and retroperitoneal leiomyosarcomas. Shpitz B; Tiomkin V; Bomstein Y; Gralkin M; Buklan H; Bernheim J; Klein E Eur J Surg Oncol; 2001 Mar; 27(2):203-8. PubMed ID: 11289760 [TBL] [Abstract][Full Text] [Related]
11. Leiomyosarcoma in soft tissue: examination of p53 status and cell proliferating factors in different locations. Konomoto T; Fukuda T; Hayashi K; Kumazawa J; Tsuneyoshi M Hum Pathol; 1998 Jan; 29(1):74-81. PubMed ID: 9445137 [TBL] [Abstract][Full Text] [Related]
12. The prognostic role of PRUNE2 in leiomyosarcoma. Zhao LR; Tian W; Wang GW; Chen KX; Yang JL Chin J Cancer; 2013 Dec; 32(12):648-52. PubMed ID: 23731771 [TBL] [Abstract][Full Text] [Related]
13. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins. Amada S; Nakano H; Tsuneyoshi M Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in retroperitoneal sarcomas: ploidy of DNA as a predictor of clinical outcome. Herman K; Gruchała A; Niezabitowski A; Gliński B; Lackowska B J Surg Oncol; 1999 May; 71(1):32-5. PubMed ID: 10362089 [TBL] [Abstract][Full Text] [Related]
15. Leiomyosarcoma: investigation of prognostic factors for risk-stratification model. Kim HJ; Cho YJ; Kim SH; Rha SY; Ahn JB; Yang WI; Lee YH; Suh JS; Roh JK; Kim KS; Choi YD; Shin KH; Kim HS Int J Clin Oncol; 2015 Dec; 20(6):1226-32. PubMed ID: 26123311 [TBL] [Abstract][Full Text] [Related]
16. Recurrence patterns of retroperitoneal leiomyosarcoma and impact of salvage surgery. Ikoma N; Torres KE; Lin HY; Ravi V; Roland CL; Mann GN; Hunt KK; Cormier JN; Feig BW J Surg Oncol; 2017 Sep; 116(3):313-319. PubMed ID: 28557016 [TBL] [Abstract][Full Text] [Related]
17. Retroperitoneal and truncal sarcomas: prognosis depends upon type not location. Perez EA; Gutierrez JC; Moffat FL; Franceschi D; Livingstone AS; Spector SA; Levi JU; Sleeman D; Koniaris LG Ann Surg Oncol; 2007 Mar; 14(3):1114-22. PubMed ID: 17206483 [TBL] [Abstract][Full Text] [Related]
18. [Leiomyosarcoma with prominent osteoclast-like giant cells: a clinicopathologic analysis of 7 cases and review of literature]. Li Y; Xu XL; Wang J Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):363-7. PubMed ID: 21914342 [TBL] [Abstract][Full Text] [Related]
19. Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases. Nicolas MM; Tamboli P; Gomez JA; Czerniak BA Hum Pathol; 2010 May; 41(5):663-71. PubMed ID: 20004935 [TBL] [Abstract][Full Text] [Related]
20. Analysis of clinical and pathological characteristics of retroperitoneal paraganglioma and associated prognostic factors. Chun C; Song L; Xu G; Shi Q; Li F; Jia X J Surg Oncol; 2024 Jul; 130(1):47-55. PubMed ID: 38864273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]